The cum-Covid recovery: comparing best practices. How to combine health and business
The main challenge associated with the spread of Covid-19 into the autumn/winter is going to be healthcare facilities’ ability to diagnose and treat a growing number of virus cases (as per all predictions) and distinguish them from seasonal flu. While Covid countermeasures will surely contribute significantly to reducing the incidence of regular flu, the annual illness will in any case continue to deplete healthcare resources.
Of pandemics and resilience. People, communities and development post Covid-19
The pandemic has unmasked the fragility of our self-assured, globalized, skill-savvy world. Even the most economically advanced countries’ primary response to this unknown virus was a low-tech social distancing, which has necessarily foregrounded the limitations of human action and knowledge. The Socratic paradox “I know that I do not know” encourages the kind of continuing fortification of basic research that calls for increased funding from the Italian government.
Never waste a crisis: what lessons to draw for the Italian health system?
The emergency that erupted in the wake of the coronavirus pandemic has some important lessons to offer the Italian healthcare system. Although it is clearly difficult to compare the healthcare models of regions affected asymmetrically by the virus, it is undeniable that coordination at various levels has proven to be one of the system’s weak points. The situation has generated confusion along the chain of control and implementation of measures, and immediate intervention regarding operational aspects – even before institutional prerogatives – is imperative.
Global health and climate change: why the Green Deal remains crucial
With lockdowns in place practically all over the world, the peak of the pandemic has morphed into a sort of vast air pollution control experiment, especially in major urban areas, whose very tangible public health benefits will certainly be short-lived and are still difficult to quantify but, in any case, point to an abnormal and clearly unsustainable “remedy”. Nevertheless, there is a considerable overlap between post-pandemic measures and environmental protection efforts.
Europe’s response to Covid-19: the way ahead
An evaluation of European economic prospects could being with the observation that we are in the throes of an exogenous shock, symmetrical in origin yet asymmetrical in its effects (the economic conditions at the outs
Lezioni di una pandemia: un’alleanza tra ricerca e industria per la salute globale
A virus that has morphed into a pandemic is bringing the world economy to its knees. Covid-19 is a phenomenon of epic proportions spreading at unprecedented speed; it is highly adept at evolving and has a powerful capacity for penetration, especially among the most vulnerable segments of the population.
Gli Stati Uniti alla prova di COVID-19
The pandemic has caught the United States at a delicate pre-electoral moment. The incumbent president is counting heavily on solid and sustained economic growth, while the Democratic Party is offering an alternative at least partly founded on a larger government role in income distribution and in providing essential services – including healthcare.
Science and technology: new resources, new challenges
The resources now available to science and technology have become immeasurable. The human brain has been creating increasingly smaller and powerful technologies that, in many cases, surpass human strength and capacities. Machines are digitalizing and perfecting nearly every sector, some of which are undergoing a revolution of unprecedented proportions.
Future by quality: Life Sciences and Research in Italy
Widespread and well-rooted start-ups – recently formed and highly innovative companies – are often seen as proxies for competition in a given territory and its ecosystem. Starts-ups in the field of life sciences are contributing to a substantial transformation of that ecosystem and to modifying relations among actors, nevertheless in a context in which the Open Innovation paradigm is less applicable and where the need to protect intellectual property prevails.
Innovative therapies and welfare: a new paradigm
The Italian and European healthcare systems are under increasing pressure as the result of a series of dynamics involving their populations and of new technological and scientific trends that are calling into question the efficacy and appropriateness of current approaches to the provision of healthcare services.
Maladies of the future: hopes and fears
Modern medicine is in continuous evolution, with discoveries and technologies unimaginable until just a few years ago. The field of immunology could not have conceived, for example, of an immune system capable of being “educated” to combat tumor cells, and yet today there is a vast amount of clinical evidence of exactly that. Advancements in research have led to various paradigm changes that have overturned previous ideas about disease and the human body.
Future by quality: life sciences and research in Italy
The participants at this National Interest event kicked off their discussions by observing that the pharmaceutical industry is one of the main agents of modernization and innovation in Italy, with its success rooted in the historical events and conditions that have helped shape the current Italian model.